Opteev’s New Multiplex Biochip Quickly Identifies COVID, Flu, and RSV
The new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
Category: Flu & Respiratory Infections
Flu & Respiratory Infections
Latest
Flu & Respiratory Infections
Latest
Visby Receives FDA EUA for Respiratory Health Test
Visby Medical has received Emergency Use Authorization (EUA) from the U.S. FDA for its Respiratory Health point of care test.
Flu & Respiratory Infections
Latest
Cold & Flu Season – Why Testing is More important than Ever
The cost of returning to normal activities may not only be a spike in COVID and the more common coronavirus the “common” cold, but influenza. Testing for both coronaviruses and influenza should be standard operating procedure at the first sign of symptoms.
Visby Receives Federal Funding to Develop Rapid At-Home COVID & Flu Test
Visby Medical received $25.5 million in federal funding to develop and validate an at-home combination Flu-Covid test from BARDA.
Read More
Influenza Home Tests as Accurate as Clinical Rapid Testing
Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings.
Read More
Flurona Cases Detected in Alabama
Compass Laboratory Services recently detected two cases of simultaneous infection by the SARS-CoV-2 virus and Influenza A.
Read More
Applied BioCode Obtains Emergency Use Authorization for Latest SARS-CoV-2 Assay
Applied BioCode has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its BioCode CoV-2 Flu Plus Assay.
Read More
Hologic Launches Multiplex COVID-19/Flu Test in North America and Europe
The Aptima SARS-CoV-2/Flu Assay from Hologic tests simultaneously for SARS-CoV-2, influenza A, and influenza B on the Panther molecular diagnostics system.
Read More
LumiraDx Submits SARS-COV-2 & Flu A/B Rapid Antigen Test for FDA EUA
LumiraDx has submitted the LumiraDx SARS-CoV-2 & Flu A/B Test to the FDA for Emergency Use Authorization (EUA).
Read More
COVID in the Time of Flu Season
In 2021, as new COVID cases continue, labs could experience the perfect storm of testing for SARS-CoV-2, influenza A and B, and RSV at the same time.
Read More
GenetWORx Offers Single Test for COVID/Influenza/RSV
GENETWORx provides a combination COVID/influenza/RSV test, and is able to provide follow-up PCR testing after a positive test in 24-48 hours.
Read More
Cold and Flu Viruses May Return With a Vengeance
The cold and flu viruses that many have avoided while staying at home and social distancing during the COVID-19 pandemic will likely run rampant again as masks come off and schools reopen, reports STAT News.
Read More
GT Molecular Launches PCR Tests for COVID-19 Delta Variant, Influenza A/B
GT Molecular has started shipping its sensitive PCR tests to monitor the coronavirus Delta variant (B.1.617.2) as well as testing and PCR kits for the detection of Influenza A and B.
Read More
Testing Tool Can Quickly Distinguish Between Viral and Bacterial Infections
Researchers showed that their testing technology can accurately distinguish between a viral and a bacterial infection for respiratory illness and the test provided results in under an hour.
Read More
ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for Covid-19, Other Viruses
Testing integrates the Spectrum Solutions saliva self-collection system with a new, advanced multiplex qPCR platform for the simultaneous RNA detection of covid-19 and its viral mutations, as well as Influenza A, B, and more.
Read More
The Pandemic Broke the Flu
This winter has been an extraordinarily quiet flu season. Scientists aren’t sure the silence will last, according to a report in The Atlantic.
Read More
QuantuMDx Scales Up to Mass Manufacture Q-POC
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read More
Point of Care Testing Can Improve Influenza Detection, Treatment
New research has shown that implementing point-of-care testing in hospitals to diagnose influenza can lead to better treatment and faster recovery for patients.
Read More